Case Study: Natural Language Processing (NLP) with Open Data for Drug Repositioning in Glioblastoma Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Case Study: Natural Language Processing (NLP) with Open Data for Drug Repositioning in Glioblastoma Therapy

Published:2023-06 Issue: Volume: Page:
ISSN:
Container-title:2023 10th IEEE Swiss Conference on Data Science (SDS)
language:
Short-container-title:

Author:

Marxer Curdin¹,Rölke Heiko¹,Alfieri Alex²,Halatsch Marc-Eric²

Affiliation:

1. FHGR,DAViS Center,Chur,Switzerland

2. Cantonal Hospital of Winterthur,Department of Neurosurgery,Winterthur,Switzerland

Publisher

IEEE

Link

http://xplorestaging.ieee.org/ielx7/10196673/10196677/10196686.pdf?arnumber=10196686

Reference48 articles.

1. Drug repurposing: progress, challenges and recommendations

2. BioCreative V CDR task corpus: a resource for chemical disease relation extraction

3. A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3

4. Analyzing grammar: An introduction;kroeger,2009

5. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP